How the innate immune system senses trouble and causes trouble

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 8, 2015, Pages 1459-1469

  Hato, Takashi ^a   Dagher, Pierre C ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD36 ANTIGEN; CRYOPYRIN; DAMAGE ASSOCIATED MOLECULAR PATTERN; ENDOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; TOLL LIKE RECEPTOR;

ARTICLE; CELL COMMUNICATION; DIABETIC NEPHROPATHY; GLOMERULONEPHRITIS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOGLOBULIN A NEPHROPATHY; INNATE IMMUNITY; KIDNEY CELL; KIDNEY INJURY; KIDNEY POLYCYSTIC DISEASE; PHAGOCYTOSIS; RENAL GRAFT DYSFUNCTION; URINARY TRACT INFECTION; URINARY TRACT OBSTRUCTION; ANIMAL; EPITHELIUM CELL; HOST PATHOGEN INTERACTION; IMMUNE SYSTEM; IMMUNOLOGY; KIDNEY; KIDNEY DISEASE; METABOLISM; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; EPITHELIAL CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; KIDNEY; KIDNEY DISEASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84938879306     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04680514     Document Type: Article

References (127)

1. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P, Antonarakis SE, Attwood J, Baertsch R, Bailey J, Barlow K, Beck S, Berry E, Birren B, Bloom T, Bork P, Botcherby M, Bray N, Brent MR, BrownDG, Brown SD, Bult C, Burton J, Butler J, CampbellRD, Carninci P, Cawley S, Chiaromonte F, Chinwalla AT, Church DM, Clamp M, Clee C, Collins FS, Cook LL, Copley RR, Coulson A, Couronne O, Cuff J, Curwen V, Cutts T, Daly M, David R, Davies J, Delehaunty KD, Deri J, Dermitzakis ET, Dewey C, DickensNJ, DiekhansM,Dodge S, Dubchak I,Dunn DM, Eddy SR, Elnitski L, Emes RD, Eswara P, Eyras E, Felsenfeld A, Fewell GA, Flicek P, Foley K, Frankel WN, Fulton LA, Fulton RS, Furey TS, Gage D, Gibbs RA, Glusman G, Gnerre S, Goldman N, Goodstadt L, Grafham D, Graves TA, Green ED, Gregory S, Guigó R, Guyer M, Hardison RC, Haussler D, Hayashizaki Y, Hillier LW, Hinrichs A, Hlavina W, Holzer T, Hsu F, Hua A, Hubbard T, Hunt A, Jackson I, Jaffe DB, Johnson LS, Jones M, Jones TA, Joy A, Kamal M, Karlsson EK, Karolchik D, Kasprzyk A, Kawai J, Keibler E, Kells C, KentWJ, Kirby A, Kolbe DL, Korf I, Kucherlapati RS, Kulbokas EJ, Kulp D, Landers T, Leger JP, Leonard S, Letunic I, Levine R, Li J, LiM, Lloyd C, Lucas S,MaB, Maglott DR, Mardis ER, Matthews L, Mauceli E, Mayer JH, McCarthy M, McCombie WR, McLaren S, McLay K, McPherson JD, Meldrim J, Meredith B, Mesirov JP, Miller W, Miner TL, Mongin E, Montgomery KT, Morgan M, Mott R, Mullikin JC, Muzny DM, Nash WE, Nelson JO, Nhan MN, Nicol R, Ning Z, Nusbaum C, O'Connor MJ, Okazaki Y, Oliver K, Overton-Larty E, Pachter L, Parra G, Pepin KH, Peterson J, Pevzner P, Plumb R, Pohl CS, Poliakov A, Ponce TC, Ponting CP, Potter S, Quail M, Reymond A, Roe BA, Roskin KM, Rubin EM, Rust AG, Santos R, Sapojnikov V, Schultz B, Schultz J, Schwartz MS, Schwartz S, Scott C, Seaman S, Searle S, Sharpe T, Sheridan A, Shownkeen R, Sims S, Singer JB, Slater G, Smit A, Smith DR, Spencer B, Stabenau A, Stange-Thomann N, Sugnet C, Suyama M, Tesler G, Thompson J, Torrents D, Trevaskis E, Tromp J, Ucla C, Ureta- Vidal A, Vinson JP, Von Niederhausern AC, Wade CM, Wall M, Weber RJ, Weiss RB, Wendl MC, West AP, Wetterstrand K, Wheeler R, Whelan S, Wierzbowski J, Willey D, Williams S, Wilson RK, Winter E, Worley KC, Wyman D, Yang S, Yang SP, Zdobnov EM, Zody MC, Lander ES; Mouse Genome Sequencing Consortium: Initial sequencing and comparative analysis of the mouse genome. Nature 420: 520-562, 2002
2. Cooper MD, Herrin BR: How did our complex immune system evolve? Nat Rev Immunol 10: 2-3, 2010
3. Kimbrell DA, Beutler B: The evolution and genetics of innate immunity. Nat Rev Genet 2: 256-267, 2001
4. Matzinger P: The danger model: A renewed sense of self. Science 296: 301-305, 2002
5. Matzinger P: The evolution of the danger theory. Interview by Lauren Constable, Commissioning Editor. Expert Rev Clin Immunol 8: 311-317, 2012
6. Matzinger P, Kamala T: Tissue-based class control: The other side of tolerance. Nat Rev Immunol 11: 221-230, 2011
7. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282: 2085-2088, 1998
8. Kawai T, Akira S: The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat Immunol 11: 373-384, 2010
9. Cheung KP, Kasimsetty SG, McKay DB: Innate immunity in donor procurement. Curr Opin Organ Transplant 18: 154-160, 2013
10. El-Achkar TM, Dagher PC: Renal Toll-like receptors: Recent advances and implications for disease. Nat Clin Pract Nephrol 2: 568-581, 2006
11. Gluba A, Banach M, Hannam S, Mikhailidis DP, Sakowicz A, Rysz J: The role of Toll-like receptors in renal diseases. Nat Rev Nephrol 6: 224-235, 2010
12. Shirali AC, Goldstein DR: Tracking the toll of kidney disease. J Am Soc Nephrol 19: 1444-1450, 2008
13. Smith KD: Toll-like receptors in kidney disease. Curr Opin Nephrol Hypertens 18: 189-196, 2009
14. Broz P, Monack DM: Newly described pattern recognition receptors team up against intracellular pathogens. Nat Rev Immunol 13: 551-565, 2013
15. Anders HJ, Muruve DA: The inflammasomes in kidney disease. J Am Soc Nephrol 22: 1007-1018, 2011
16. Ting JP, Duncan JA, Lei Y: How the noninflammasome NLRs function in the innate immune system. Science 327: 286-290, 2010
17. Du P, Fan B, Han H, Zhen J, Shang J,Wang X, Li X, ShiW, Tang W, Bao C, Wang Z, Zhang Y, Zhang B, Wei X, Yi F: NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy. Kidney Int 84: 265-276, 2013
18. Kayagaki N, Wong MT, Stowe IB, Ramani SR, Gonzalez LC, Akashi-Takamura S, Miyake K, Zhang J, Lee WP, Muszy_nski A, Forsberg LS, Carlson RW, Dixit VM: Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341: 1246-1249, 2013
19. Strowig T, Henao-Mejia J, Elinav E, Flavell R: Inflammasomes in health and disease. Nature 481: 278-286, 2012
20. Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 20: 197-216, 2002
21. Akira S, Uematsu S, Takeuchi O: Pathogen recognition and innate immunity. Cell 124: 783-801, 2006
22. Kagan JC: Signaling organelles of the innate immune system. Cell 151: 1168-1178, 2012
23. NakamuraN, Lill JR, PhungQ, Jiang Z, Bakalarski C, deMazière A, Klumperman J, Schlatter M, Delamarre L, Mellman I: Endosomes are specialized platforms for bacterial sensing and NOD2 signalling. Nature 509: 240-244, 2014
24. Williams SCP. Microbial social network.HHMI Bulletin 26: 14- 17, 2013
25. Anders HJ, Schaefer L: Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis. J Am Soc Nephrol 25: 1387- 1400, 2014
26. XiaoW, MindrinosMN, Seok J, Cuschieri J, Cuenca AG, GaoH, Hayden DL, Hennessy L, Moore EE, Minei JP, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Brownstein BH, Mason PH, Baker HV, Finnerty CC, Jeschke MG, López MC, Klein MB, Gamelli RL, Gibran NS, Arnoldo B, Xu W, Zhang Y, Calvano SE, McDonald-Smith GP, Schoenfeld DA, Storey JD, Cobb JP, Warren HS, Moldawer LL, Herndon DN, Lowry SF, Maier RV, Davis RW, Tompkins RG; Inflammation and Host Response to Injury Large-Scale Collaborative Research Program: A genomic storm in critically injured humans. J Exp Med 208: 2581-2590, 2011
27. Rosin DL, Okusa MD: Dangers within: DAMP responses to damage and cell death in kidney disease. J Am Soc Nephrol 22: 416-425, 2011
28. ChenGY, Tang J, Zheng P, Liu Y: CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323: 1722-1725, 2009
29. Beutler BA: TLRs and innate immunity. Blood 113: 1399-1407, 2009
30. Vyas JM, Van der Veen AG, Ploegh HL: The known unknowns of antigen processing and presentation. Nat Rev Immunol 8: 607- 618, 2008
31. Blum JS, Wearsch PA, Cresswell P: Pathways of antigen processing. Annu Rev Immunol 31: 443-473, 2013
32. Neefjes J, Jongsma ML, Paul P, Bakke O: Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11: 823-836, 2011
33. Leelahavanichkul A, Bocharov AV, Kurlander R, Baranova IN, Vishnyakova TG, Souza AC, Hu X, Doi K, Vaisman B, Amar M, Sviridov D, Chen Z, Remaley AT, Csako G, Patterson AP, Yuen PS, Star RA, Eggerman TL: Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice. J Immunol 188: 2749-2758, 2012
34. Tran M, Tam D, Bardia A, Bhasin M, Rowe GC, Kher A, Zsengeller ZK, Akhavan-SharifMR, Khankin EV, SaintgeniezM, David S, Burstein D, Karumanchi SA, Stillman IE, Arany Z, Parikh SM: PGC-1a promotes recovery after acute kidney injury during systemic inflammation in mice. J Clin Invest 121: 4003- 4014, 2011
35. Szeto HH, Liu S, Soong Y, Wu D, Darrah SF, Cheng FY, Zhao Z, Ganger M, Tow CY, Seshan SV: Mitochondria-targeted peptide accelerates ATP recovery and reduces ischemic kidney injury. J Am Soc Nephrol 22: 1041-1052, 2011
36. Takasu O, Gaut JP,Watanabe E, To K, Fagley RE, Sato B, Jarman S, Efimov IR, Janks DL, Srivastava A, Bhayani SB, Drewry A, Swanson PE, Hotchkiss RS: Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med 187: 509-517, 2013
37. Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV: Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16: 535-543, 1p, 143, 2010
38. Holthoff JH,Wang Z, Seely KA, Gokden N,Mayeux PR: Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury. Kidney Int 81: 370-378, 2012
39. Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, Wittebole X, Dugernier T, Perrotin D, Tidswell M, Jauregui L, Krell K, Pachl J, Takahashi T, Peckelsen C, Cordasco E, Chang CS, Oeyen S, Aikawa N, Maruyama T, Schein R, Kalil AC, Van Nuffelen M, Lynn M, Rossignol DP, Gogate J, Roberts MB, Wheeler JL, Vincent JL; ACCESS Study Group: Effect of eritoran, an antagonist ofMD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA 309: 1154-1162, 2013
40. Tidswell M, Tillis W, Larosa SP, Lynn M, Wittek AE, Kao R, Wheeler J, Gogate J, Opal SM; Eritoran Sepsis Study Group: Phase 2 trial of eritoran tetrasodium(E5564), a toll-like receptor 4 antagonist, in patients with severe sepsis. Crit Care Med 38: 72-83, 2010
41. Rice TW, Wheeler AP, Bernard GR, Vincent JL, Angus DC, Aikawa N, Demeyer I, Sainati S, Amlot N, Cao C, IiM,Matsuda H, Mouri K, Cohen J: A randomized, double-blind, placebocontrolled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med 38: 1685-1694, 2010
42. Ayres JS, Schneider DS: Tolerance of infections. Annu Rev Immunol 30: 271-294, 2012
43. Medzhitov R, Schneider DS, Soares MP: Disease tolerance as a defense strategy. Science 335: 936-941, 2012
44. Jamieson AM, Pasman L, Yu S, Gamradt P, Homer RJ, Decker T, Medzhitov R: Role of tissue protection in lethal respiratory viralbacterial coinfection. Science 340: 1230-1234, 2013
45. Rae F, Woods K, Sasmono T, Campanale N, Taylor D, Ovchinnikov DA, Grimmond SM, Hume DA, Ricardo SD, Little MH: Characterisation and trophic functions of murine embryonic macrophages based upon the use of a Csf1r-EGFP transgene reporter. Dev Biol 308: 232-246, 2007
46. Kim BS, Lim SW, Li C, Kim JS, Sun BK, Ahn KO, Han SW, Kim J, Yang CW: Ischemia-reperfusion injury activates innate immunity in rat kidneys. Transplantation 79: 1370-1377, 2005
47. Rusai K, Sollinger D, Baumann M, Wagner B, Strobl M, Schmaderer C, Roos M, Kirschning C, Heemann U, Lutz J: Tolllike receptors 2 and 4 in renal ischemia/reperfusion injury. Pediatr Nephrol 25: 853-860, 2010
48. Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, Hiemstra PS, van 't Veer C: In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation. J Immunol 168: 1286-1293, 2002
49. Anders HJ: Toll-like receptors and danger signaling in kidney injury. J Am Soc Nephrol 21: 1270-1274, 2010
50. Lu CY, Winterberg PD, Chen J, Hartono JR: Acute kidney injury: A conspiracy of Toll-like receptor 4 on endothelia, leukocytes, and tubules. Pediatr Nephrol 27: 1847-1854, 2012
51. GoodDW, George T,Watts BA3rd: Lipopolysaccharide directly alters renal tubule transport through distinct TLR4-dependent pathways in basolateral and apical membranes. Am J Physiol Renal Physiol 297: F866-F874, 2009
52. Laestadius A, Söderblom T, Aperia A, Richter-Dahlfors A: Developmental aspects of Escherichia coli-induced innate responses in rat renal epithelial cells. Pediatr Res 54: 536-541, 2003
53. Shigeoka AA, Holscher TD, King AJ, Hall FW, Kiosses WB, Tobias PS, Mackman N, McKay DB: TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol 178: 6252-6258, 2007
54. Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, Nagai Y, TakeuchiO, Akira S,Matsuguchi T: Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 169: 2026-2033, 2002
55. Van Amersfoort ES, Van Berkel TJ, Kuiper J: Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock. Clin Microbiol Rev 16: 379-414, 2003
56. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF, Chadban SJ: TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117: 2847-2859, 2007
57. Kalakeche R, Hato T, Rhodes G, Dunn KW, El-Achkar TM, Plotkin Z, Sandoval RM, Dagher PC: Endotoxin uptake by S1 proximal tubular segment causes oxidative stress in the downstream S2 segment. J Am Soc Nephrol 22: 1505-1516, 2011
58. Pulskens WP, Teske GJ, Butter LM, Roelofs JJ, van der Poll T, Florquin S, Leemans JC: Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS ONE 3: e3596, 2008
59. Zhang B, Ramesh G, Uematsu S, Akira S, Reeves WB: TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol 19: 923-932, 2008
60. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, Kirschning CJ, Akira S, van der Poll T, Weening JJ, Florquin S: Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115: 2894-2903, 2005
61. Krü ger B, Krick S, Dhillon N, Lerner SM, Ames S, Bromberg JS, Lin M, Walsh L, Vella J, Fischereder M, Krämer BK, Colvin RB, Heeger PS, Murphy BT, Schröppel B: Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A 106: 3390- 3395, 2009
62. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187-191, 2000
63. Rallabhandi P, Bell J, Boukhvalova MS, Medvedev A, Lorenz E, Arditi M, Hemming VG, Blanco JC, Segal DM, Vogel SN: Analysis of TLR4 polymorphic variants: new insights into TLR4/ MD-2/CD14 stoichiometry, structure, and signaling. J Immunol 177: 322-332, 2006
64. Zhao H, Perez JS, Lu K, George AJ, Ma D: Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury. Am J Physiol Renal Physiol 306: F801-F811, 2014
65. Leventhal JS, Schröppel B: Toll-like receptors in transplantation: sensing and reacting to injury. Kidney Int 81: 826-832, 2012
66. Deng M, Scott MJ, Loughran P, Gibson G, Sodhi C, Watkins S, Hackam D, Billiar TR: Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of TLR4 during sepsis. J Immunol 190: 5152-5160, 2013
67. Rushworth SA, Chen XL, Mackman N, Ogborne RM, O'Connell MA: Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via Nrf2 and protein kinase C. J Immunol 175: 4408-4415, 2005
68. Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV: Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 118: 1657-1668, 2008
69. Wuthrich RP, Glimcher LH, Yui MA, Jevnikar AM, Dumas SE, Kelley VE: MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int 37: 783- 792, 1990
70. Li H, Nord EP: CD40 ligation stimulates MCP-1 and IL-8 production, TRAF6 recruitment, and MAPK activation in proximal tubule cells. Am J Physiol Renal Physiol 282: F1020-F1033, 2002
71. Niemann-Masanek U, Mueller A, Yard BA,Waldherr R, van der Woude FJ: B7-1 (CD80) and B7-2 (CD 86) expression in human tubular epithelial cells in vivo and in vitro. Nephron 92: 542- 556, 2002
72. Wahl P, Schoop R, Bilic G, Neuweiler J, Le HirM, Yoshinaga SK, Wü thrich RP: Renal tubular epithelial expression of the costimulatory molecule B7RP-1 (inducible costimulator ligand). J Am Soc Nephrol 13: 1517-1526, 2002
73. Deckers JG, De Haij S, van der Woude FJ, van der Kooij SW, Daha MR, van Kooten C: IL-4 and IL-13 augment cytokine- and CD40-induced RANTES production by human renal tubular epithelial cells in vitro. J Am Soc Nephrol 9: 1187-1193, 1998
74. Hagerty DT, Allen PM: Processing and presentation of self and foreign antigens by the renal proximal tubule. J Immunol 148: 2324-2330, 1992
75. Jevnikar AM, Wuthrich RP, Takei F, Xu HW, Brennan DC, Glimcher LH, Rubin-Kelley VE: Differing regulation and function of ICAM-1 and class II antigens on renal tubular cells. Kidney Int 38: 417-425, 1990
76. Kuroiwa T, Schlimgen R, Illei GG, McInnes IB, Boumpas DT: Distinct T cell/renal tubular epithelial cell interactions define differential chemokine production: Implications for tubulointerstitial injury in chronic glomerulonephritides. J Immunol 164: 3323-3329, 2000
77. Chassin C, Goujon JM, Darche S, du Merle L, Bens M, Cluzeaud F, Werts C, Ogier-Denis E, Le Bouguénec C, Buzoni-Gatel D, Vandewalle A: Renal collecting duct epithelial cells react to pyelonephritis-associated Escherichia coli by activating distinct TLR4-dependent and -independent inflammatory pathways. J Immunol 177: 4773-4784, 2006
78. Chassin C, Vimont S, Cluzeaud F, Bens M, Goujon JM, Fernandez B, Hertig A, Rondeau E, Arlet G, Hornef MW, Vandewalle A: TLR4 facilitates translocation of bacteria across renal collecting duct cells. J Am Soc Nephrol 19: 2364-2374, 2008
79. Gauer S, Sichler O, Obermü ller N, Holzmann Y, Kiss E, Sobkowiak E, Pfeilschifter J, GeigerH,Mü hl H, Hauser IA: IL-18 is expressed in the intercalated cell of human kidney. Kidney Int 72: 1081-1087, 2007
80. Paragas N, Qiu A, Zhang Q, Samstein B, Deng SX, Schmidt-Ott KM, Viltard M, Yu W, Forster CS, Gong G, Liu Y, Kulkarni R, Mori K, Kalandadze A, Ratner AJ, Devarajan P, Landry DW, D'Agati V, Lin CS, Barasch J: The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat Med 17: 216-222, 2011
81. Liu J, Krautzberger AM, Sui SH, Hofmann OM, Chen Y, Baetscher M, Grgic I, Kumar S, Humphreys BD, Hide WA, McMahon AP: Cell-specific translational profiling in acute kidney injury. J Clin Invest 124: 1242-1254, 2014
82. Westphalen K, Gusarova GA, Islam MN, Subramanian M, Cohen TS, Prince AS, Bhattacharya J: Sessile alveolar macrophages communicate with alveolar epithelium to modulate immunity. Nature 506: 503-506, 2014
83. Jaitin DA, Kenigsberg E, Keren-Shaul H, Elefant N, Paul F, Zaretsky I, Mildner A, Cohen N, Jung S, Tanay A, Amit I: Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types. Science 343: 776-779, 2014
84. BanasMC, Banas B, Hudkins KL, Wietecha TA, Iyoda M, Bock E, Hauser P, Pippin JW, Shankland SJ, Smith KD, Stoelcker B, Liu G, Gröne HJ, Krämer BK, Alpers CE: TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol 19: 704-713, 2008
85. Floege J, Gröne HJ: Progression of renal failure: What is the role of cytokines? Nephrol Dial Transplant 10: 1575-1586, 1995
86. Chen J, John R, Richardson JA, Shelton JM, Zhou XJ,Wang Y,Wu QQ, Hartono JR, Winterberg PD, Lu CY: Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney Int 79: 288-299, 2011
87. Vasko R, Ratliff BB, Bohr S,Nadel E, Chen J, Xavier S, Chander P, Goligorsky MS: Endothelial peroxisomal dysfunction and impaired pexophagy promotes oxidative damage in lipopolysaccharideinduced acute kidney injury. Antioxid Redox Signal 19: 211-230, 2013
88. Andonegui G, Zhou H, Bullard D, Kelly MM, Mullaly SC, McDonald B, Long EM, Robbins SM, Kubes P: Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic Gram-negative bacterial infection. J Clin Invest 119: 1921-1930, 2009
89. Campanholle G, Mittelsteadt K, Nakagawa S, Kobayashi A, Lin SL, Gharib SA, Heinecke JW, Hamerman JA, Altemeier WA, Duffield JS: TLR-2/TLR-4 TREM-1 signaling pathway is dispensable in inflammatory myeloid cells during sterile kidney injury. PLoS ONE 8: e68640, 2013
90. Pulskens WP, Rampanelli E, Teske GJ, Butter LM, Claessen N, Luirink IK, van der Poll T, Florquin S, Leemans JC: TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J Am Soc Nephrol 21: 1299-1308, 2010
91. Humphreys BD, Xu F, Sabbisetti V, Grgic I, Naini SM,Wang N, Chen G, Xiao S, Patel D, Henderson JM, Ichimura T, Mou S, Soeung S, McMahon AP, Kuchroo VK, Bonventre JV: Chronic epithelial kidney injury molecule-1 expression causes murine kidney fibrosis. J Clin Invest 123: 4023-4035, 2013
92. MrugM, Zhou J,Woo Y, Cui X, Szalai AJ, Novak J, ChurchillGA, Guay-Woodford LM: Overexpression of innate immune response genes in a model of recessive polycystic kidney disease. Kidney Int 73: 63-76, 2008
93. Lin M, Yiu WH, Wu HJ, Chan LY, Leung JC, Au WS, Chan KW, Lai KN, Tang SC: Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol 23: 86- 102, 2012
94. GrigoryevDN, Liu M, Hassoun HT, Cheadle C, Barnes KC, Rabb H: The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol 19: 547-558, 2008
95. Mulay SR, Kulkarni OP, Rupanagudi KV, Migliorini A, Darisipudi MN, Vilaysane A, Muruve D, Shi Y, Munro F, Liapis H, Anders HJ: Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1b secretion. J Clin Invest 123: 236-246, 2013
96. Yu XQ, Li M, Zhang H, Low HQ,Wei X,Wang JQ, Sun LD, Sim KS, Li Y, Foo JN,WangW, Li ZJ, Yin XY, Tang XQ, Fan L, Chen J, Li RS, Wan JX, Liu ZS, Lou TQ, Zhu L, Huang XJ, Zhang XJ, Liu ZH, Liu JJ: A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. Nat Genet 44: 178-182, 2012
97. Suzuki H, Suzuki Y, Narita I, Aizawa M, Kihara M, Yamanaka T, Kanou T, Tsukaguchi H, Novak J, Horikoshi S, Tomino Y: Tolllike receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol 19: 2384-2395, 2008
98. Fairfax BP, Humburg P, Makino S, Naranbhai V,Wong D, Lau E, Jostins L, Plant K, Andrews R, McGee C, Knight JC: Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 343: 1246949, 2014
99. Oberbarnscheidt MH, Zeng Q, Li Q, Dai H, Williams AL, ShlomchikWD, Rothstein DM, Lakkis FG: Non-self recognition by monocytes initiates allograft rejection. J Clin Invest 124: 3579-3589, 2014
100. O'Neill LA, Golenbock D, Bowie AG: The history of Toll-like receptors - redefining innate immunity. Nat Rev Immunol 13: 453-460, 2013
101. Bessede A, Gargaro M, Pallotta MT, Matino D, Servillo G, Brunacci C, Bicciato S, Mazza EM, Macchiarulo A, Vacca C, Iannitti R, Tissi L, Volpi C, Belladonna ML, Orabona C, Bianchi R, Lanz TV, Platten M, Della Fazia MA, Piobbico D, Zelante T, Funakoshi H, Nakamura T, Gilot D, Denison MS, Guillemin GJ, DuHadaway JB, Prendergast GC, Metz R, Geffard M, Boon L, Pirro M, Iorio A, Veyret B, Romani L, Grohmann U, Fallarino F, Puccetti P: Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 511: 184-190, 2014
102. Hwang YH, Ro H, Choi I, Kim H, Oh KH, Hwang JI, Park MH, Kim S, Yang J, Ahn C: Impact of polymorphisms of TLR4/CD14 and TLR3 on acute rejection in kidney transplantation. Transplantation 88: 699-705, 2009
103. DuclouxD,DeschampsM, Yannaraki M, FerrandC, Bamoulid J, Saas P, Kazory A, Chalopin JM, Tiberghien P: Relevance of Tolllike receptor-4 polymorphisms in renal transplantation. Kidney Int 67: 2454-2461, 2005
104. Nogueira E, Ozaki KS, Macusso GD, Quarim RF, Câmara NO, Pacheco-Silva A: Incidence of donor and recipient toll-like receptor-4 polymorphisms in kidney transplantation. Transplant Proc 39: 412-414, 2007
105. Palmer SM, Burch LH, Mir S, Smith SR, Kuo PC, Herczyk WF, Reinsmoen NL, Schwartz DA: Donor polymorphisms in Tolllike receptor-4 influence the development of rejection after renal transplantation. Clin Transplant 20: 30-36, 2006
106. Wu H, Noordmans GA, O'BrienMR, Ma J, Zhao CY, Zhang GY, Kwan TK, Alexander SI, Chadban SJ: Absence of MyD88 signaling induces donor-specific kidney allograft tolerance. J Am Soc Nephrol 23: 1701-1716, 2012
107. Brown HJ, Lock HR,Wolfs TG, BuurmanWA, Sacks SH, Robson MG:Toll-like receptor 4 ligationonintrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J Am Soc Nephrol 18: 1732-1739, 2007
108. Brown HJ, Sacks SH, Robson MG: Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis. J Am Soc Nephrol 17: 1931-1939, 2006
109. Wö rnle M, SchmidH, Banas B,MerkleM, Henger A, RoederM, Blattner S, Bock E, Kretzler M, Gröne HJ, Schlöndorff D: Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 168: 370-385, 2006
110. Sadanaga A,Nakashima H, AkahoshiM,Masutani K, Miyake K, Igawa T, Sugiyama N, Niiro H, Harada M: Protection against autoimmune nephritis in MyD88-deficient MRL/lpr mice. Arthritis Rheum 56: 1618-1628, 2007
111. Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Gröne HJ, Schlöndorff D: Activation of toll-like receptor-9 induces progression of renal disease inMRL-Fas(lpr) mice. FASEB J 18: 534- 536, 2004
112. Pawar RD, Ramanjaneyulu A, Kulkarni OP, Lech M, Segerer S, Anders HJ: Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol 18: 1721-1731, 2007
113. Zhou J,Ouyang X, Cui X, Schoeb TR, Smythies LE, JohnsonMR, Guay-Woodford LM, Chapman AB, Mrug M: Renal CD14 expression correlates with the progression of cystic kidney disease. Kidney Int 78: 550-560, 2010
114. Ragnarsdó ttir B, SamuelssonM,Gustafsson MC, Leijonhufvud I, Karpman D, Svanborg C: Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J InfectDis 196: 475-484, 2007
115. Patole PS, Schubert S, Hildinger K, Khandoga S, Khandoga A, Segerer S, Henger A, Kretzler M, Werner M, Krombach F, Schlöndorff D, Anders HJ: Toll-like receptor-4: Renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis. Kidney Int 68: 2582-2587, 2005
116. Andersen-Nissen E, Hawn TR, SmithKD, NachmanA, Lampano AE, Uematsu S, Akira S, Aderem A: Cutting edge: Tlr5-/- mice are more susceptible to Escherichia coli urinary tract infection. J Immunol 178: 4717-4720, 2007
117. Bishop BL, Duncan MJ, Song J, Li G, Zaas D, Abraham SN: Cyclic AMP-regulated exocytosis of Escherichia coli from infected bladder epithelial cells. Nat Med 13: 625-630, 2007
118. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S: A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303: 1522-1526, 2004
119. Reiser J, von GersdorffG, LoosM,Oh J, Asanuma K,Giardino L, Rastaldi MP, Calvaresi N, Watanabe H, Schwarz K, Faul C, Kretzler M, Davidson A, Sugimoto H, Kalluri R, Sharpe AH, Kreidberg JA, Mundel P: Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 113: 1390- 1397, 2004
120. Cunningham PN,Wang Y, Guo R, He G, Quigg RJ: Role of Tolllike receptor 4 in endotoxin-induced acute renal failure. J Immunol 172: 2629-2635, 2004
121. Castoldi A, Braga TT, Correa-Costa M, Aguiar CF, Bassi EJ, Correa-Silva R, Elias RM, Salvador F, Moraes-Vieira PM, Cenedeze MA, Reis MA, Hiyane MI, Pacheco-Silva Á, Gonçalves GM, Saraiva Câmara NO: TLR2, TLR4 and the MYD88 signaling pathway are crucial for neutrophil migration in acute kidney injury induced by sepsis. PLoS ONE 7: e37584, 2012
122. Watts BA 3rd, George T, Sherwood ER, Good DW: A two-hit mechanism for sepsis-induced impairment of renal tubule function. Am J Physiol Renal Physiol 304: F863-F874, 2013
123. Yasuda H, Leelahavanichkul A, Tsunoda S, Dear JW, Takahashi Y, Ito S, Hu X, Zhou H, Doi K, Childs R, Klinman DM, Yuen PS, Star RA: Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am J Physiol Renal Physiol 294: F1050-F1058, 2008
124. Wu H, Ma J, Wang P, Corpuz TM, Panchapakesan U, Wyburn KR, Chadban SJ: HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol 21: 1878-1890, 2010
125. Kulkarni OP, Hartter I, Mulay SR, Hagemann J, Darisipudi MN, Kumar Vr S, Romoli S, Thomasova D, Ryu M, Kobold S, Anders HJ: Toll-like receptor 4-induced IL-22 accelerates kidney regeneration. J Am Soc Nephrol 25: 978-989, 2014
126. Shigeoka AA, Kambo A,Mathison JC, King AJ, HallWF, da Silva Correia J, Ulevitch RJ, McKay DB: Nod1 and nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury. J Immunol 184: 2297-2304, 2010
127. Shigeoka AA, Mueller JL, Kambo A, Mathison JC, King AJ, Hall WF, Correia JS, Ulevitch RJ, Hoffman HM, McKay DB: An inflammasome-independent role for epithelial-expressedNlrp3 in renal ischemia-reperfusion injury. J Immunol 185: 6277- 6285, 2010